Clinical Trials Directory

Trials / Completed

CompletedNCT05600413

Citrulline Supplementation On Vascular Responsiveness and Function in Postmenopausal Women

L-Citrulline Supplementation to Improve Vascular Function and Responsiveness at Rest and During Exercise in Postmenopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Texas Tech University · Academic / Other
Sex
Female
Age
50 Years – 79 Years
Healthy volunteers
Accepted

Summary

The objective of this project is to provide evidence that L-Citrulline (L-CIT) supplementation can improve vascular function at rest and in response to exercise in postmenopausal women.

Detailed description

L-CIT is a non-essential amino acid that is a precursor to L-arginine, the substrate used to produce an important vasodilatory molecule called nitric oxide. The purpose of this study is to identify the effects of 6 grams of L-CIT for 4 weeks on vascular function (endothelial function, blood flow, muscle oxygenation, and blood pressure) at rest and in response to different stressors (cold pressor test, isometric and dynamic exercise).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-Citrulline4 weeks of L-Citrulline supplementation (6 grams/day)
DIETARY_SUPPLEMENTPlacebo4 weeks of Placebo (crystalline cellulose)

Timeline

Start date
2020-07-07
Primary completion
2022-04-27
Completion
2022-04-27
First posted
2022-10-31
Last updated
2022-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05600413. Inclusion in this directory is not an endorsement.

Citrulline Supplementation On Vascular Responsiveness and Function in Postmenopausal Women (NCT05600413) · Clinical Trials Directory